Cyrano Therapeutics

Developer of pharmaceutical therapies for smell and taste loss

placeWashington, DC, District Of Columbia, United States calendar_todayFounded 2014 groups7 employees language cyranotherapeutics.com

Innovation

14 patent families (5 granted) — focus: Human necessities, Physics & computing; filing pace accelerating. Cited 2,796 times.

YearFilings
20171
20181
20193
20202
20212
20223
20237
20249
20255
20262

Social engagement

Social engagement: 733 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Remiges Ventures, Lumira Ventures, Florida Opportunity Fund.

Investor typeCountShare
Venture capital480%
Accelerator & incubator120%

Recent activity

19 Jun 2026
Product launch
CYR-064
17 Jun 2026
Product launch
CYR-064
12 Jun 2026
Product launch
pharmaceutical therapy for smell restoration
Coming soon